Chandra Lovejoy, MS
Chandra Lovejoy, MS
Vice President of Regulatory Affairs
Endocyte, Inc.
3000 Kent Avenue
Suite A1-100
West Lafayette,
IN
USA
47906
Papers:
448 - Poster Session B
CA-125 as a response marker for vintafolide+pegylated liposomal doxorubicin vs pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer: the PRECEDENT trial